About | Slow Ledger 29

About

Slow Ledger 29 (Willow Helix) is an independent information resource created to help people distinguish investigational findings from established care when seeking context on ibogaine and opioid withdrawal. Our work foregrounds evidence, harm awareness, and careful limits of certainty.

This page describes our editorial approach, scope, and guiding principles.

Our editorial approach

We gather and summarise evidence with an emphasis on primary literature, public registries, and official guidance. When we reference outcomes or study protocols we aim to link to source material and to contextual summaries so readers can see the underlying record; for example, we place internal case-summary links in-line where they clarify method or provenance and use authoritative sources such as peer review on Wikipedia to explain general vetting processes.

Our curation includes synthesis of clinical registries and government advisories where available — we reference official guidance to ground risk statements, for instance linking to a relevant national clinical advisory when describing how safety monitoring is ordinarily handled, as is outlined by many clinical quality frameworks on US federal pages like NIH.

What we check

Source provenance — trial registry entry, peer review status
Method transparency — sample, selection, and monitoring
Risk reporting — adverse events and cardiac screening
Regulatory status — jurisdictional access and approvals

We do not offer medical recommendations. Our summaries are intended to help readers locate evidence and understand uncertainty.

For context about particular treatment reports we sometimes link to community-maintained compilations; for example, readers may find case-level notes discussed in specialized compendia like the entries catalogued by practitioners and observers in field-focused wikis such as the treatment discussion around pilots on ibogaine treatment for Air Force pilots.

Who this is for

Our audience includes people affected by opioid withdrawal, family and supporters, and clinicians seeking plainspoken summaries. We guide readers toward primary evidence rather than offering clinical guidance; if users are exploring clinical services we link to descriptive accounts rather than endorsing providers — for example, descriptive community reports such as treatment notes for martial artists appear as contextual entries like ibogaine treatment for martial artists where relevant to pattern recognition.

How we source and vet content

Our editorial process prioritises verifiable material: registry identifiers, peer-reviewed publications, and regulatory documents. We label content by source type and confidence level and flag gaps or conflicting reports. Where practical, we link to registries and trial pages, and we reference professional standards for reporting harms similar to practices described by public health institutions and university methodology guides like those on CDC or university-method pages such as those hosted by major research institutions.

We also use community-maintained reports as contextual notes; these are tagged clearly and kept separate from our evidence summaries. Examples include advocacy or development reporting such as announcements from organisations working on ibogaine development documented on pages like Psyence Biomed supports U.S. push for ibogaine development.

Editorial principles

Our work is guided by concise principles that shape selection, framing, and disclosure.

Evidence before claims — prioritise primary sources and transparent methods

Harm awareness — foreground safety, monitoring, and adverse-event data

Plain language — explain methods and uncertainty without technical obfuscation

Independence — we do not offer treatment, licensing, or endorsements

Respect for uncertainty — clearly label low-confidence findings and gaps

We document provenance for contentious items and link to descriptive seed-report resources such as ibogaine seeds for readers tracing source material.

Independent by design

Slow Ledger 29 is an independent information resource. We are not a clinic, medical provider, or licensed treatment center. Our material is informational and does not constitute medical or legal advice. Readers seeking care should consult licensed professionals or regulated services in their jurisdiction; regulatory access summaries and jurisdictional notes are available in our regulatory pages and contextual collections (for example, topic-specific injury and PTSD case summaries can appear alongside clinical notes such as Arizona study: ibogaine, PTSD, and brain injuries).

If you arrived here looking for our homepage narrative, our front page summarises mission and topical entry points — see the opening context at the site root to reorient to reading pathways on this project: visit the site introduction.

Frequently asked questions

Is this a treatment provider?

No. Slow Ledger 29 is an independent editorial resource. We do not provide clinical services, and our content is not medical or legal advice. For regulated care or clinical access, consult licensed providers and local regulations.

How do you decide what to publish?

We prioritise verifiable evidence and clear provenance. When summarising case reports or community documentation, we link inline to source pages and clearly label confidence. We also cross-reference public registries and institutional guidance during review — practices similar to data-curation norms described on university guidance pages such as Harvard research guides.

Do you link to community compendia?

Yes, where those compendia help locate source material. We keep those references distinct from our evidence summaries and label them appropriately; examples include community-maintained treatment logs and seed collections such as the documentation found at treatment notes for Air Force pilots and other specific case corpora.